This 2-day continuing education conference will focus on the latest advancements in lung cancer care, offering oncologists and healthcare providers insights into emerging therapies and treatment strategies. The conference will cover a wide range of topics, from foundational knowledge like next-generation sequencing (NGS) to more complex clinical discussions on selecting optimal therapies for conditions like EGFR mutant NSCLC. Attendees will have the opportunity to learn from leading experts in lung cancer research and care, with a program designed to meet the needs of professionals at all stages of their careers.

The conference will feature engaging presentations from top lung cancer investigators, providing valuable opportunities for networking and professional growth. In addition to in-depth topic reviews, the event will include interactive panel discussions and live Q&A sessions, allowing attendees to gain a deeper understanding of cutting-edge treatment options. This dynamic setting is designed to foster collaboration and ensure that participants are well-equipped with the knowledge needed to enhance patient care in an increasingly complex field. The TLC Conference Chairs are Tina Cascone, MD, PhD (MD Anderson Cancer Center) and Stephen Liu, MD (Georgetown University).